Board of Sandu Pharmaceuticals recommend that the Board of Directors of the Company at its meeting held on 12 August 2022 inter alia have recommended the final dividend of Rs 075 per equity Share ieEarlier board meeting dated on 12-August-2022 decided final dividend of Rs 007 to Rs 075 per share ie 75Percentagerevised dividend approved in Board Meeting on 12-August-2022 subject to the approval of the shareholders
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.